Stereotaxis, Inc. (NYSEAMERICAN:STXS) Shares Sold by Essex Investment Management Co. LLC

Essex Investment Management Co. LLC reduced its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,212,964 shares of the company's stock after selling 197,165 shares during the period. Essex Investment Management Co. LLC owned 1.43% of Stereotaxis worth $2,766,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Geode Capital Management LLC lifted its position in shares of Stereotaxis by 7.2% in the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company's stock valued at $2,840,000 after acquiring an additional 93,253 shares in the last quarter. State Street Corp raised its stake in Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company's stock valued at $1,388,000 after purchasing an additional 36,518 shares during the period. Bank of New York Mellon Corp lifted its holdings in Stereotaxis by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 193,109 shares of the company's stock worth $440,000 after purchasing an additional 22,280 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Stereotaxis by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company's stock worth $341,000 after buying an additional 15,491 shares in the last quarter. Finally, Traynor Capital Management Inc. bought a new position in shares of Stereotaxis during the fourth quarter worth $366,000. 45.35% of the stock is currently owned by institutional investors.

Remove Ads

Stereotaxis Stock Performance

STXS traded down $0.05 on Thursday, hitting $1.78. The company had a trading volume of 359,029 shares, compared to its average volume of 459,309. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29. The company's fifty day moving average is $2.24. The firm has a market cap of $150.82 million, a P/E ratio of -6.36 and a beta of 1.54.

Insider Transactions at Stereotaxis

In related news, Director Paul J. Isaac purchased 38,000 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was purchased at an average price of $1.81 per share, with a total value of $68,780.00. Following the completion of the purchase, the director now owns 87,299 shares of the company's stock, valued at approximately $158,011.19. The trade was a 77.08 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 18.52% of the company's stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.